Lincomycin, clindamycin and their applications

Abstract Lincomycin and clindamycin are lincosamide antibiotics used in clinical practice. Both antibiotics are bacteriostatic and inhibit protein synthesis in sensitive bacteria. They may even be bactericidal at the higher concentrations that can be reached in vivo . Clindamycin is usually more active than lincomycin in the treatment of bacterial infections, in particular those caused by anaerobic species; and it can also be used for the treatment of important protozoal diseases, e.g. malaria, most effectively in combination with primaquine. Resistance to lincomycin and clindamycin may be caused by methylation of 23S ribosomal RNA, modification of the antibiotics by specific enzymes or active efflux from the periplasmic space.

[1]  B. J. Magerlein Modification of lincomycin. , 1971, Advances in applied microbiology.

[2]  B. Meyers,et al.  Susceptibilities of Gram-Negative Bacteria to Combinations of Antimicrobial Agents In Vitro , 1975, Antimicrobial Agents and Chemotherapy.

[3]  J. Klastersky,et al.  Bactericidal Activity of the Combinations of Gentamicin with Clindamycin or Chloramphenicol Against Species of Escherichia coli and Bacteroides fragilis , 1977, Antimicrobial Agents and Chemotherapy.

[4]  G. Ridgway,et al.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. , 1978, The British journal of venereal diseases.

[5]  F. Cox Human babesiosis , 1980, Nature.

[6]  R. Goering,et al.  Effects of clindamycin on derepression of β-lactamases in Gram-negative bacteria , 1983 .

[7]  R. Goering,et al.  Effects of clindamycin on derepression of beta-lactamases in gram-negative bacteria. , 1983, The Journal of antimicrobial chemotherapy.

[8]  P. Schlievert,et al.  Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. , 1984, The Journal of infectious diseases.

[9]  D. Eschenbach,et al.  [Bacterial vaginosis]. , 1985, Archives of gynecology.

[10]  I. Phillips,et al.  Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres. , 1991, The Journal of antimicrobial chemotherapy.

[11]  F. Baquero,et al.  Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes , 1992, Antimicrobial Agents and Chemotherapy.

[12]  Inducible expression of ribosomal clindamycin resistance in Bacteroides vulgatus , 1992, Antimicrobial Agents and Chemotherapy.

[13]  J. Ballesta,et al.  Antibiotic sensitivity of ribosomes from wild-type and clindamycin resistant Bacteroides vulgatus strains. , 1992, The Journal of antimicrobial chemotherapy.

[14]  I. Brook,et al.  Significant recovery of nonsporulating anaerobic rods from clinical specimens. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  C. Ryan,et al.  Flavobacterial sepsis in massively burned pediatric patients. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Gourdeau,et al.  Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers , 1994, Antimicrobial Agents and Chemotherapy.

[17]  I. Podglajen,et al.  Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the Bacteroides fragilis group. , 1994, The Journal of antimicrobial chemotherapy.

[18]  K. Watanabe,et al.  Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  D. Roos,et al.  In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii , 1995, Antimicrobial agents and chemotherapy.

[20]  J. Knapp,et al.  Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease , 1995, Antimicrobial agents and chemotherapy.

[21]  O. Dupuy,et al.  Antibiotiques et paludisme. Revue de la littérature , 1995 .

[22]  D. Roos Molecular genetic tools for the identification and analysis of drug targets in Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.

[23]  H. B. Fung,et al.  Treatment regimens for patients with toxoplasmic encephalitis. , 1996, Clinical therapeutics.

[24]  A. Bouvet Infections sévères dues à Streptococcus pyogenes ou streptocoque du groupe A , 1996 .

[25]  U. Groß,et al.  Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.

[26]  E. Wald,et al.  Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[27]  S. Ōmura,et al.  Semisynthetic modification of antibiotic lincomycin. , 1996, The Journal of antibiotics.

[28]  L. Bastian,et al.  Bacillus-cereus-Pneumonie nach Thoraxtrauma. Fallbeispiel und Literaturübersicht , 1997 .

[29]  N. F. Jacobs,et al.  Drug-Induced Clostridium difficile-Associated Disease , 1997, Drug safety.

[30]  A. ...,et al.  The use of antibiotics : a clinical review of antibacterial, antifungal, and antiviral drugs , 1997 .

[31]  R. Leblay,et al.  La babésiose humaine en 1997 , 1997 .

[32]  G. Regel,et al.  [Bacillus cereus pneumonia after thoracic trauma. Case report and review of the literature]. , 1997, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[33]  F. Schildberg,et al.  Klebsiella pneumoniae Necrotizing F asciitis Associated w ith D iabetes a nd L iver C irrhosis , 2000 .

[34]  N. Sadick,et al.  Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin. , 1997, Journal of the American Academy of Dermatology.

[35]  P. Brasseur,et al.  [Human babesiosis in 1997]. , 1997, La Revue de medecine interne.

[36]  A. Cooper Systematic review of Propionibacterium acnes resistance to systemic antibiotics , 1998, The Medical journal of Australia.

[37]  M. Smieja,et al.  Current indications for the use of clindamycin: A critical review. , 1998, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[38]  J. Fishman Treatment of Infection Due toPneumocystis carinii , 1998, Antimicrobial Agents and Chemotherapy.

[39]  B. Mordmüller,et al.  [Malaria therapy in the era of chloroquine resistance]. , 1998, Wiener klinische Wochenschrift.

[40]  B. Allaouchiche,et al.  [Diffusion in bone tissue of antibiotics]. , 1999, Presse medicale.

[41]  C. Veyssier-Belot,et al.  [Erysipelas, cellulitis and other severe Streptococcus pyogenes skin infections]. , 1999, Presse medicale.

[42]  C. Noli,et al.  Macrolides and lincosamides. , 1999, Veterinary dermatology.

[43]  M. Wilcox,et al.  Antibiotics and Clostridium difficile. , 1999, Microbes and infection.

[44]  M. Matsuoka [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[45]  M. Falagas,et al.  Bacteroides, Prevotella, and Porphyromonas species: a review of antibiotic resistance and therapeutic options. , 2000, International journal of antimicrobial agents.

[46]  D. Stevens Streptococcal toxic shock syndrome associated with necrotizing fasciitis. , 2000, Annual review of medicine.

[47]  G. Bertho,et al.  Lincomycin and clindamycin conformations. A fragment shared by macrolides, ketolides and lincosamides determined from TRNOE ribosome-bound conformations. , 2000, Bioorganic & medicinal chemistry.

[48]  W. S. Champney,et al.  Specific Inhibition of 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells by 16-Membered Macrolide, Lincosamide, and Streptogramin B Antibiotics , 2000, Current Microbiology.

[49]  J. French,et al.  Bacterial vaginosis in pregnancy. , 2000, Obstetrical & gynecological survey.

[50]  P. Conrad,et al.  Human babesiosis: an emerging tick-borne disease. , 2000, International journal for parasitology.

[51]  C. Stratton Mechanisms of bacterial resistance to antimicrobial agents. , 2000, Le Journal medical libanais. The Lebanese medical journal.

[52]  B. Forbes,et al.  Activation of clindamycin phosphate by human skin , 2001, Journal of applied microbiology.

[53]  J. Distler,et al.  Aminoglycosides and Sugar Components in Other Secondary Metabolites , 2001 .

[54]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[55]  E. Mylonakis,et al.  Clostridium difficile--Associated diarrhea: A review. , 2001, Archives of internal medicine.

[56]  A. Bryskier Anti-anaerobic activity of antibacterial agents , 2001, Expert opinion on investigational drugs.

[57]  G. Plosker,et al.  Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. , 2002, American journal of clinical dermatology.

[58]  C. Walker,et al.  Rationale for use of antibiotics in periodontics. , 2002, Journal of periodontology.

[59]  I. Brook The prophylaxis and treatment of anthrax. , 2002, International journal of antimicrobial agents.

[60]  B. Lell,et al.  Clindamycin as an Antimalarial Drug: Review of Clinical Trials , 2002, Antimicrobial Agents and Chemotherapy.

[61]  P. Hsueh,et al.  High Incidence of Cefoxitin and Clindamycin Resistance among Anaerobes in Taiwan , 2002, Antimicrobial Agents and Chemotherapy.

[62]  G. Plosker,et al.  Clindamycin/Benzoyl Peroxide Gel , 2002 .

[63]  I. Brook Clinical review: Bacteremia caused by anaerobic bacteria in children , 2002, Critical care.

[64]  K. Hikosaka,et al.  Photoinactivation and recovery of photosystem II in Chenopodium album leaves grown at different levels of irradiance and nitrogen availability. , 2002, Functional plant biology : FPB.

[65]  A. Frank,et al.  Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children , 2003, Current opinion in infectious diseases.

[66]  M. Stevenson,et al.  Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. , 2003, The Journal of antimicrobial chemotherapy.

[67]  H. Hahn,et al.  Susceptibilities of Campylobacter jejuni Isolates from Germany to Ciprofloxacin, Moxifloxacin, Erythromycin, Clindamycin, and Tetracycline , 2003, Antimicrobial Agents and Chemotherapy.

[68]  P. Branny,et al.  Detection and characterization of feline Bartonella henselae in the Czech Republic. , 2003, Veterinary microbiology.

[69]  G. Macfarlane,et al.  Nondigestible Oligosaccharides Enhance Bacterial Colonization Resistance against Clostridium difficile In Vitro , 2003, Applied and Environmental Microbiology.

[70]  Elizabeth A. Coyle Targeting Bacterial Virulence: The Role of Protein Synthesis Inhibitors in Severe Infections , 2003, Pharmacotherapy.

[71]  T. Řezanka,et al.  Lincomycin, cultivation of producing strains and biosynthesis , 2004, Applied Microbiology and Biotechnology.

[72]  M. Maekawa,et al.  Detection of Macrolide Resistance in Streptococcus pneumoniae , 2003, Chemotherapy.

[73]  W J Cunliffe,et al.  Antibiotic‐resistant acne: lessons from Europe , 2003, The British journal of dermatology.

[74]  H. Bartels,et al.  Antibiotics acting on the translational machinery , 2003, Journal of Cell Science.

[75]  D. Guay Treatment of bacterial skin and skin structure infections , 2003, Expert opinion on pharmacotherapy.

[76]  K. Carroll,et al.  Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  I. Vass,et al.  The interaction of visible and UV-B light during photodamage and repair of Photosystem II , 2004, Photosynthesis Research.

[78]  R. Vanholder,et al.  Immunomodulating effects of antibiotics: Literature review , 1996, Infection.